John Corradi
Director, Proteomics and Bioinformatics Arvinas
PhD in neuroscience from The Rockefeller University; post-doctoral training at NIH and The Jackson Laboratory; bioinformatics scientist supporting neuroscience drug discovery at AstraZeneca and BMS; six years at Arvinas leading Proteomics and Bioinformatics as part of the Platform Biology group.
Seminars
Wednesday 4th February 2026
Proteomics Along the TPD Pipeline – Enabling Lead Optimization Through Clinical Biomarker Development
3:45 pm
- Exploring how proteomics is employed throughout the drug discovery process for targeted protein degradation
- Outlining how global proteomics helps guide medicinal chemistry and understand compound effects
- Discovering how targeted MS-based proteomics and alternative platforms can provide essential and exploratory clinical biomarkers
